The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients (ITT population) diagnosed with endoscopically proven GERD grade A,B,C received esomeprazole (40 mg once daily (o.d.), n=90) or pantoprazole (40 mg o.d., n=90). Healing and relief from GERD-related symptoms were assessed at first and final visit (after 4 or 8 weeks of treatment). Esomeprazole 40 mg provided significantly greater healing than pantoprazole 40 mg after 4 weeks of treatment in patients with EE (77.8% vs. 72.2%). Esomeprazole-treated patients were healed after up to 8 weeks of treatment similar th...
BACKGROUND: Tegoprazan is a novel potassium-competitive acid blocker that has a fast onset of action...
BACKGROUND: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at ...
Background & aimsAZD0865 belongs to a new class of acid-suppressing agents with rapid onset of actio...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Background: The objective of this study was to compare the efficacy of pantoprazole and esomeprazole...
Background - Esomeprazole, an S-isomer of omeprazole, is the first proton pump inhibitor developed a...
Background: Gastroesophageal reflux disease (GERD) is a common chronic, relapsing condition that car...
Introduction: The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once...
Introduction: The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once...
INTRODUCTION: Esomeprazole, the first proton pump inhibitor to be developed as an optical isomer, ha...
OBJECTIVE: The objective of this systematic review is to determine whether Esomeprazole (Nexium) is ...
Background.: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at...
BACKGROUND: Esomeprazole, an S-isomer of omeprazole, is the first proton pump inhibitor developed as...
Aim of review. To present literature data on efficacy and safety of esomeprazole for the treatment o...
BACKGROUND: Tegoprazan is a novel potassium-competitive acid blocker that has a fast onset of action...
BACKGROUND: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at ...
Background & aimsAZD0865 belongs to a new class of acid-suppressing agents with rapid onset of actio...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to he...
Background: The objective of this study was to compare the efficacy of pantoprazole and esomeprazole...
Background - Esomeprazole, an S-isomer of omeprazole, is the first proton pump inhibitor developed a...
Background: Gastroesophageal reflux disease (GERD) is a common chronic, relapsing condition that car...
Introduction: The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once...
Introduction: The aim of this study was to assess the efficacy and safety of esomeprazole 40 mg once...
INTRODUCTION: Esomeprazole, the first proton pump inhibitor to be developed as an optical isomer, ha...
OBJECTIVE: The objective of this systematic review is to determine whether Esomeprazole (Nexium) is ...
Background.: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at...
BACKGROUND: Esomeprazole, an S-isomer of omeprazole, is the first proton pump inhibitor developed as...
Aim of review. To present literature data on efficacy and safety of esomeprazole for the treatment o...
BACKGROUND: Tegoprazan is a novel potassium-competitive acid blocker that has a fast onset of action...
BACKGROUND: Previous studies have shown similar effects of rabeprazole and omeprazole, when used at ...
Background & aimsAZD0865 belongs to a new class of acid-suppressing agents with rapid onset of actio...